The Case of Daniel Terzi: Trauma with Clinical Care

  • Rebecca Fein
  • Anna H. RosenEmail author


In exposure to a traumatic event (such as violence, assault, natural disaster, or critical medical illness) involves a real or threatened injury to oneself or others, an individual can develop post-traumatic stress disorder (PTSD). Traumatic events such as violence, assault, natural disaster or critical medical illness which involve a real or threatened injury to oneself or others can lead to the development of posttraumatic stress disorder (PTSD). This disorder involves psychological and physiological symptoms including intrusive thoughts, nightmares, and flashbacks, as well as hypervigilance, avoidance of reminders of the trauma, and sleep disturbance. Other psychiatric comorbidities are high in individuals with PTSD, and therefore careful attention must be paid to evaluating for comorbid mood, anxiety, and substance use disorders. Depending on an individual’s preference, first-line treatment can involve medication management or psychotherapy that is typically trauma-focused in nature. The combination of these treatment approaches can aptly address both the acute symptoms of PTSD and the more dynamic issues seen in this disorder. With treatment, individuals can experience improvement in their overall functioning.


Adjustment disorder Alpha-1 adrenergic receptor blockers Flashbacks Hypervigilance Post-traumatic stress disorder (PTSD) Trauma-focused therapy 


  1. 1.
    American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 5th ed. Arlington: American Psychiatric Publishing; 2013.CrossRefGoogle Scholar
  2. 2.
    Courtois CA, Sonis J, Fairbank JA, Friedman M, Jones R, Roberts J, Schulz P. Clinical practice guideline for the treatment of posttraumatic stress disorder (PTSD) in adults. American Psychological Association. 2017.Google Scholar
  3. 3.
    Bisson J, Andrew M. Psychological treatment of post-traumatic stress disorder (PTSD). Cochrane Database Syst Rev. 2007;(3):CD003388.Google Scholar
  4. 4.
    Goldstein RB, Smith SM, Chou SP, et al. The epidemiology of DSM-5 posttraumatic stress disorder in the United States: results from the national epidemiologic survey on alcohol and related conditions-III. Soc Psychiatry Psychiatr Epidemiol. 2016;51:1137.CrossRefGoogle Scholar
  5. 5.
    Raskind MA, Peskind ER, Chow B, et al. Trial of prazosin for post-traumatic stress disorder in military veterans. N Engl J Med. 2018;378:507–17.CrossRefGoogle Scholar
  6. 6.
    Kar N. Cognitive behavioral therapy for the treatment of posttraumatic stress disorder: a review. Neuropsychiatr Dis Treat. 2011;7:167–81.CrossRefGoogle Scholar
  7. 7.
    Stein DJ, Ipser JC, Seedat S. Pharmacotherapy for posttraumatic stress disorder (PTSD). Cochrane Database Syst Rev. 2006;(1):CD002795.Google Scholar

Suggested Reading

  1. Goodnight JRM, Ragsdale KA, Rauch SAM, Rothbaum BO. Psychotherapy for PTSD: an evidence-based guide to a theranostic approach to treatment. Prog Neuro-Psychopharmacol Biol Psychiatry. 2019;88:418.CrossRefGoogle Scholar
  2. Zoellner LA, Roy-Byrne PP, Mavissakalian M, Feeny NC. Doubly randomized preference trial of prolonged exposure versus sertraline for treatment of PTSD. Am J Psychiatr. 2018.Google Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  1. 1.Weill Cornell Medical College/New York-Presbyterian HospitalNew YorkUSA
  2. 2.Weill Cornell Medical College/New York-Presbyterian Hospital-Westchester DivisionWhite PlainsUSA

Personalised recommendations